IPRIPR2016-01563Terminated
Mylan Pharmaceuticals Inc. et al.v.Boehringer Ingelheim Pharmaceuticals Inc. et al.
IPR challenge of US 8673927.
Type
IPR
Filed
Aug 10, 2016
Instituted
Feb 3, 2017
Decided
—
Patent
Application
12946193
Inventor
Klaus DUGI et al
Granted
Mar 18, 2014
01
Timeline
3 milestones
2016-08-10Petition filed
2017-02-03Institution
2017-07-18Terminated
02
Parties & counsel
Petitioner
Mylan Pharmaceuticals Inc. et al.
Counsel
Parker, Thomaset al
Patent Owner
Boehringer Ingelheim Pharmaceuticals Inc. et al.
Counsel
Ben-Ami, Leoraet al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →